Clinically, based on the expression of hormone receptors: estrogen receptor (ER), progesterone receptor (PR) and HER2 (human epidermal growth factor receptor 2, ERBB2), breast cancer is classified into three major subtypes: Luminal, HER2-enriched and triple-negative breast cancer (TNBC) [22]. This evidence concerns the gene PGR and triple-negative breast carcinoma.